Exploring Salivary Biomarkers in Pediatric Obesity: A Scoping Review

Abstract

Childhood obesity and overweight are linked to subclinical inflammatory conditions. The present manuscript aimed to undertake a scoping review exploring the relationship between childhood obesity and salivary biomarkers to answer the following question: "Are salivary biomarkers trustful factors/indicators for childhood obesity?" The main search terms used were: "obesity and salivary biomarkers and children" (Pubmed, Scielo, Scopus, Embase databases: 1999-2025). Assessed articles were carefully classified according to a predetermined criterion (Newcastle-Ottawa Scale), and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) were considered. Papers involving children >13 years, duplicates/triplicates, literature reviews, and non-related to the question addressed were excluded. More than 30 salivary biomarkers were assessed in the thirteen studies appraised. Three studies were rated as having a high level of evidence, two as moderate, and eight as having a low level. Fourteen biomarkers were found to be significantly increased in childhood obesity/overweight (p < 0.05): leptin, insulin, α-amylase, tumor necrosis factor α, interleukin 6, vascular endothelial growth factor-A, C-reactive protein, monocyte chemotactic protein-1, resistin, phosphate, nitric oxide, interleukin 1β, uric acid and fetuin-A; and three were found to be significantly decreased (p < 0.05): adiponectin, secretory immunoglobulin A, and interleukin-12p70. In conclusion, the present review supported the idea that saliva might be a promising diagnostic tool in early life and that it is a significant source of obesity biomarkers in children.

Keywords: biomarkers; pediatric obesity; saliva.

Figure 1

Flow diagram of the literature search in the present review.

Figure 2

Statistically significant salivary biomarkers identified in the appraised studies.